Technical Analysis for SIGA - SIGA Technologies Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
B | 8.66 | -1.14% | -0.10 |
SIGA closed down 1.14 percent on Wednesday, April 24, 2024, on 48 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: May 2
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Spinning Top | Other | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
20 DMA Resistance | Bearish | -1.14% | |
Stochastic Buy Signal | Bullish | -1.14% | |
Pocket Pivot | Bullish Swing Setup | -1.14% | |
Up 3 Days in a Row | Strength | -1.14% | |
Oversold Stochastic | Weakness | -1.14% | |
Strong but Oversold | Other | 3.71% | |
Oversold Stochastic | Weakness | 3.71% |
Alert | Time |
---|---|
Down 2 % | about 7 hours ago |
Possible NR7 | about 8 hours ago |
Possible Inside Day | about 8 hours ago |
60 Minute Opening Range Breakdown | about 10 hours ago |
Fell Below 10 DMA | about 10 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2024
SIGA Technologies, Inc. is a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats. The company’s lead product is TPOXX®, also known as tecovirimat and ST-246®, an orally administered and IV formulation antiviral drug that targets orthopoxvirus infections. While TPOXX® is not yet approved as safe and effective by the U.S. Food & Drug Administration, it is a novel small-molecule drug of which 2 million courses have been delivered to the Strategic National Stockpile under Project BioShield.
Sector: Healthcare
Industry: Biotechnology
Keywords: Chemical Compounds Organic Chemistry Antiviral Drug Biological Warfare Small Molecule Monkeypox Poxviruses Orthopoxvirus
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Chemical Compounds Organic Chemistry Antiviral Drug Biological Warfare Small Molecule Monkeypox Poxviruses Orthopoxvirus
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 10.0 |
52 Week Low | 3.9263 |
Average Volume | 900,321 |
200-Day Moving Average | 5.34 |
50-Day Moving Average | 6.97 |
20-Day Moving Average | 8.88 |
10-Day Moving Average | 8.67 |
Average True Range | 0.47 |
RSI (14) | 57.81 |
ADX | 44.69 |
+DI | 25.29 |
-DI | 15.08 |
Chandelier Exit (Long, 3 ATRs) | 8.58 |
Chandelier Exit (Short, 3 ATRs) | 9.28 |
Upper Bollinger Bands | 9.73 |
Lower Bollinger Band | 8.04 |
Percent B (%b) | 0.37 |
BandWidth | 18.99 |
MACD Line | 0.38 |
MACD Signal Line | 0.57 |
MACD Histogram | -0.1886 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 9.09 | ||||
Resistance 3 (R3) | 9.10 | 8.97 | 9.02 | ||
Resistance 2 (R2) | 8.97 | 8.86 | 8.96 | 9.00 | |
Resistance 1 (R1) | 8.81 | 8.79 | 8.75 | 8.80 | 8.97 |
Pivot Point | 8.68 | 8.68 | 8.65 | 8.67 | 8.68 |
Support 1 (S1) | 8.53 | 8.57 | 8.46 | 8.52 | 8.35 |
Support 2 (S2) | 8.39 | 8.50 | 8.39 | 8.32 | |
Support 3 (S3) | 8.24 | 8.39 | 8.30 | ||
Support 4 (S4) | 8.23 |